RxSight, Inc. to Present at the Bank of America Healthcare Conference
April 22 2022 - 9:00AM
(NASDAQ: RXST) -- RxSight, Inc., an
ophthalmic medical device company dedicated to improving the vision
of patients following cataract surgery, today announced plans to
participate in the upcoming Bank of America Healthcare Conference.
RxSight’s management is scheduled to present Tuesday, May 10,
2022, at 12:00pm PT / 3:00pm ET. Interested parties may access a
live and archived webcast of the presentation on the “Investors”
section of the company’s website at:
https://investors.rxsight.com/.
About RxSight, Inc.RxSight, Inc. is a
commercial-stage medical technology company dedicated to improving
the vision of patients following cataract surgery. The RxSight®
Light Adjustable Lens system, comprised of the RxSight Light
Adjustable Lens® (LAL®), RxSight Light Delivery Device (LDD™) and
accessories, is the first and only commercially available
intraocular lens (IOL) technology that enables doctors to customize
and optimize visual acuity for patients after cataract surgery. The
LAL now features ActivShield™ technology, a revolutionary UV
protection layer built into the lens. Additional information about
RxSight can be found at www.rxsight.com.
Investor Relations Contact:Philip Taylor
Gilmartin Group415.937.5406IR@rxsight.com
Company Contact:Shelley ThunenRxSight,
Inc.949-521-7830IR@rxsight.com
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Sep 2024 to Oct 2024
RxSight (NASDAQ:RXST)
Historical Stock Chart
From Oct 2023 to Oct 2024